Abstract
NAT2*5 allele was found in 54.8% healthy children and 35.9% children with bronchial asthma,i.e. the risk of bronchial asthma was considerably lower in individuals carryingNAT2*5 allele.NAT2*5 allele manifests itself in both homo- and heterozygous states.
Similar content being viewed by others
References
Bronchial Asthma. Global Strategy [in Russian],Pulmonologiya, Supplement (1996).
V. V. Ivanova L. N. Bulovskaya, G. F. Zheleznikova, and O. A. Drobachenko,Immunologiya,6, 45–47 (1997).
D. Hickman, J. R. Palamanda, J. D. Unadkay, and E. Sim,Biochem. Pharmacol.,50, No. 5, 697–703 (1995).
A. L. Hubbard, D. J. Harrison, A. H. Wyllie,et al., Gut.,41, 229–234 (1997).
P. D. Josephy, D. H. Evans, A. Parikh, and F. P. Guengerich,Chem. Res. Toxicol.,11, 70–74 (1998).
J. Jouve, J. Herault, H. Tournade, and J. P. Muh,J. Chromatogr.,574, 9–15 (1992).
J. T. Li,Curr. Opin. Pulm. Med.,3, 10–16 (1997).
K. Orzechovska-Juzwenko, P. Milejski, J. Patkowski,et al., Int. J. Clin. Pharmacol. Ther. Toxicol.,28, No. 10, 420–425 (1990).
N. Pearse,Int. J. Epidemiol.,22, 1189–1192 (1993).
A. Sandford, T. Weir, and P. Pare,Am. J. Respir. Crit. Care Med.,153, 1749–1765 (1996).
J. A. Smith, P. S. Helliwell, A. Isdaleet al., J. Pineal. Res.,10, No. 1, 14–17 (1991).
K. P. Vatsis, W. W. Weber, D. A. Bell,et al., Pharmacogenetics,5, 1–18 (1995).
W. Wang and N. Ballatori,Pharmacol. Rev.,50, No. 3, 335–354 (1998).
W. W. Weber and L. W. Hein,—Ibid.,,37 25–79 (1985).
N. M. Woolhouse, M. M. Quereshi, S. M. A. Bastaki,et al., Pharmacogenetics 7, 73–82 (1997).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Makarova, S.I., Vavilin, V.A., Lyakhovich, V.V. et al. AlleleNAT2 *5determines resistance to bronchial asthma in children . Bull Exp Biol Med 129, 575–577 (2000). https://doi.org/10.1007/BF02434881
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF02434881